Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from the Institut Pasteur

Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine

Intravacc launches hybrid business model to drive innovation and growth

Intravacc’s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine

Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine

Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer

Intravacc announces formation of Scientific Advisory Board

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek